Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers

Biliary tract cancers (BTC) are rare but aggressive. Due to limited anti-tumor effects of current second- and later-line treatment regimens, novel treatment options are required. Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil (FOLFnal-IRI) achieved promising results as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Allo, Gabriel, Can, Ahu Damla, Wahba, Roger, Vogel, Nils, Goeser, Tobias, Kütting, Fabian, Waldschmidt, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764657/
https://www.ncbi.nlm.nih.gov/pubmed/35070301
http://dx.doi.org/10.3892/mco.2021.2485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764657/
https://www.ncbi.nlm.nih.gov/pubmed/35070301
http://dx.doi.org/10.3892/mco.2021.2485

Ejemplares similares